Treatment for late-stage prostate cancer patients: getting closer to a solution

The European Research Council (ERC) has devoted an ERC story to Xavier Salvatella, ICREA researcher and head of the Laboratory of Molecular Biophysics. Salvatella holds an ERC Consolidator Grant to study how the protein androgen receptor folds and how mutations in this protein are linked to drug resistance developed in late-stage prostate cancer patients. This research may open the door to new therapies.

The ERC piece includes the "Meet Our Scientists" video devoted to the researcher—the launch of which inspired this European organisation to write this article about him. The aim of the “Meet Our Scientists” series is to promote IRB Barcelona scientists, attract talent, and spread the word about the benefits of biomedical research.